{"id":"pirfenidone-capsules-600mg","safety":{"commonSideEffects":[{"rate":"23%","effect":"Cough"},{"rate":"21%","effect":"Dyspnea"},{"rate":"20%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1256391","moleculeType":"Small molecule","molecularWeight":"185.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Pirfenidone is a small molecule that inhibits the production of transforming growth factor-beta (TGF-β), a key cytokine involved in fibrosis.","oneSentence":"Antifibrotic agent","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:45:28.369Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Idiopathic pulmonary fibrosis"}]},"trialDetails":[{"nctId":"NCT07388680","phase":"PHASE2, PHASE3","title":"Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Continent Pharmaceutical Co, Ltd.","startDate":"2026-02-28","conditions":"Radiation-induced Lung Injury, Immune-related Pneumonia","enrollment":298},{"nctId":"NCT05531955","phase":"PHASE2","title":"Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-08-05","conditions":"Myocardial Fibrosis","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Pirfenidone Capsules（600mg）","genericName":"Pirfenidone Capsules（600mg）","companyName":"Beijing Continent Pharmaceutical Co, Ltd.","companyId":"beijing-continent-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antifibrotic agent Used for Idiopathic pulmonary fibrosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}